Drug Shortage Report for SANDOZ LEVOFLOXACIN

Last updated on 2023-03-06

Report ID 169681
Drug Identification Number 02298651
Brand name SANDOZ LEVOFLOXACIN
Common or Proper name LEVOFLOXACIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 750MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 50FCT BO
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-21
Estimated end date 2023-02-17
Actual end date 2023-02-10
Shortage status Resolved
Updated date 2023-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2023-03-06 French Compare
v8 2023-03-06 English Compare
v7 2022-12-28 French Compare
v6 2022-12-28 English Compare
v5 2022-09-27 French Compare
v4 2022-09-27 English Compare
v3 2022-09-22 English Compare
v2 2022-09-21 French Compare
v1 2022-09-21 English Compare

Showing 1 to 9 of 9